BackgroundCheck.run
Search For

Matthew Rupert Kaser, 674793 Ewing Rd, Hayward, CA 94546

Known as:
Matthew R Kaser Matthew Rupert Dr Kaser Matthew Kaser Dphil Matt R Kaser Matthew R Wikler
Related to:
Christopher Herbert Wikler 28

Matthew Kaser Phones & Addresses

4793 Ewing Rd, Castro Valley, CA 94546    510-7279123   

4703 Ewing Rd, Castro Valley, CA 94546   

4792 Ewing Rd, Castro Valley, CA 94546   

Hayward, CA   

Long Beach, CA   

Alameda, CA   

Get Report
Control this profile

Mentions for Matthew Rupert Kaser

Matthew Kaser resumes & CV records

Resumes

Matthew Kaser Photo 18

Owner

Location:
San Francisco, CA
Industry:
Law Practice
Work:
California State University East Bay - Departments of Biological Sciences and Chemistry and Biochemistry since Apr 2013
PT Lecturer L.S.B. Leakey Foundation - San Francisco since Jul 2009
Trustee Bell & Associates - San Francisco since Sep 2003
Owner Castro Valley Educational Foundation since Jun 2001
Board Member Mendel Biotechnology Oct 2001 - Apr 2003
Associate Director, Patent Group Incyte Pharmaceuticals 1997 - 2001
Patent Agent
Education:
University of Oxford 1984 - 1988
D.Phil., Biochemistry University of Wales, Bangor 1975 - 1978
B.Sc. (General), Zoology, Applied Zoology, Biochemistry
Skills:
Biotechnology, Start Ups, Biochemistry, Intellectual Property, Lifesciences, Patents, Life Sciences, Due Diligence, Research, Patent Prosecution, Public Speaking, Medical Devices, Venture Capital, Strategy, Strategic Planning, Entrepreneurship, Patent Law, Marketing Strategy
Interests:
Etc
Education
Molecular Anthropology
Cosmology
Science and Technology
Evo Devo
Languages:
French
Spanish
Matthew Kaser Photo 19

Matthew Kaser

Publications & IP owners

Us Patents

Mammalian Toxicological Response Markers

US Patent:
6372431, Apr 16, 2002
Filed:
Nov 19, 1999
Appl. No.:
09/443184
Inventors:
Mary Jane Cunningham - Sunnyvale CA
Gary B. Zweiger - Mountain View CA
Matthew R. Kaser - Castro Valley CA
Scott R. Panzer - Sunnyvale CA
Jeffrey J. Seilhamer - Los Altos Hills CA
Henry Yue - Sunnyvale CA
Mariah R. Baughn - San Leandro CA
Yalda Azimzai - Hayward CA
Preeti Lal - Santa Clara CA
Assignee:
Incyte Genomics, Inc. - Palo Alto CA
International Classification:
C12Q 168
US Classification:
435 6, 435 4, 435 71, 435DIG 1, 435DIG 14, 435DIG 17, 536231, 436501
Abstract:
The present invention relates to mammalian nucleic acid and protein molecules comprising a plurality of nucleic acid and protein molecules. The mammalian nucleic acid molecules can be used as hybridizable array elements in a microarray in diagnostic and therapeutic applications including detecting metabolic and toxicological responses, and in monitoring drug mechanism of action. The protein molecules can be used in a pharmaceutical composition. The present invention also relates to methods for screening compounds and therapeutics for metabolic responses indicative of a toxic compound or molecule.

Transcription Factor Regulatory Protein

US Patent:
6465200, Oct 15, 2002
Filed:
Apr 17, 2001
Appl. No.:
09/836941
Inventors:
Matthew R. Kaser - Castro Valley CA
Mariah R. Baughn - San Leandro CA
Assignee:
Incyte Genomics, Inc. - Palo Alto CA
International Classification:
G01N 3353
US Classification:
435 78, 4241851, 530350, 530413
Abstract:
The invention provides a mammalian nucleic acid sequence and fragments thereof. It also provides for the use of these nucleic acid sequences in a model system for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with expression of the mammalian nucleic acid sequence. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid sequence.

Mammalian Imidazoline Receptor

US Patent:
6475752, Nov 5, 2002
Filed:
Jul 30, 1999
Appl. No.:
09/364206
Inventors:
Preeti Lal - Santa Clara CA
Y. Tom Tang - San Jose CA
Mariah R. Baughn - San Leandro CA
Matthew R. Kaser - Castro Valley CA
Assignee:
Incyte Genomics, Inc. - Palo Alto CA
International Classification:
C12P 2106
US Classification:
435 691, 435 701, 435 711, 435 712, 4352523, 4353201, 435325, 435471, 435 6, 536 235
Abstract:
The invention provide a mammalian nucleic acid molecule and fragments thereof. It also provides for the use of the mammalian nucleic acid molecule for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with its expression and for the production of a model system. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid molecule. The invention further provides a mammalian protein or portions thereof. The invention still further provides for the use of the nucleic acid molecule and protein in assays to detect or purify ligands.

Tapasin-Like Protein

US Patent:
6692923, Feb 17, 2004
Filed:
Aug 20, 2001
Appl. No.:
09/933561
Inventors:
Preeti G. Lal - Santa Clara CA
Matthew R. Kaser - Castro Valley CA
Mariah R. Baughn - San Leandro CA
Assignee:
Incyte Corporation - Palo Alto CA
International Classification:
G01N 3353
US Classification:
435 71, 435 792, 436172, 436501, 436512, 436513, 436547, 436804, 436514, 436 2, 436 12, 436 21, 436530, 436324, 436350, 436827
Abstract:
The invention provides a cDNA which encodes tapasin-like protein. It also provides for the use of the cDNA, protein, and antibody in the diagnosis, prognosis, treatment and evaluation of therapies for cancer. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.

Genes Expressed In Treated Human C3A Liver Cell Cultures

US Patent:
6727066, Apr 27, 2004
Filed:
Jul 30, 2001
Appl. No.:
09/919039
Inventors:
Matthew R. Kaser - Castro Valley CA
Assignee:
Incyte Corporation - Palo Alto CA
International Classification:
C12Q 168
US Classification:
435 6, 4353201, 4352528, 435174, 435183, 382129, 382133, 382153, 382173, 382286, 382291, 702 19, 702 22, 935 10, 935 24, 935 72, 536 221
Abstract:
The present invention relates to a composition comprising a plurality of cDNAs which are differentially expressed in treated human C3A liver cell cultures and which may be used entirely or in part to diagnose, to stage, to treat, or to monitor the progression or treatment of liver disorders such as hyperlipidemia.

Polynucleotides Encoding Human Presenilin Variant

US Patent:
6783955, Aug 31, 2004
Filed:
Jun 29, 2001
Appl. No.:
09/895035
Inventors:
Chandra Arvizu - Menlo Park CA
Lynn E. Murry - Fayetteville AR
Matthew R. Kaser - Castro Valley CA
Assignee:
Incyte Corporation - Palo Alto CA
International Classification:
C12P 2106
US Classification:
435 691, 4352523, 4353201, 435325, 536 231, 530350, 530300
Abstract:
The invention provides a cDNA which encodes human presenilin variant. It also provides for the use of the cDNA and protein in the diagnosis, prognosis, treatment and evaluation of therapies for cancer or neurodegenerative or immune disorders. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.

Human Transmembrane Proteins

US Patent:
8206947, Jun 26, 2012
Filed:
Nov 8, 2006
Appl. No.:
11/594148
Inventors:
Y. Tom Tang - San Jose CA, US
Preeti G. Lal - Santa Clara CA, US
Jennifer L. Jackson - Santa Cruz CA, US
Henry Yue - Sunnyvale CA, US
Karl J. Guegler - Menlo Park CA, US
Neil C. Corley - Castro Valley CA, US
Olga Bandman - Mountain View CA, US
Chandra S. Arvizu - San Diego CA, US
Gina A. Gorgone Simone - Earleville MD, US
Matthew R. Kaser - Castro Valley CA, US
Mariah R. Baughn - Los Angeles CA, US
Janice K. Au-Young - Brisbane CA, US
Assignee:
Incyte Corporation - Palo Alto CA
International Classification:
C12P 21/06
C12P 21/04
C07H 21/04
US Classification:
435 691, 435 701, 536 235, 536 241
Abstract:
The invention provides human transmembrane proteins (HTMPN) and polynucleotides which identify and encode HTMPN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HTMPN.

Human Membrane-Spanning Proteins

US Patent:
2001002, Sep 27, 2001
Filed:
Mar 30, 2001
Appl. No.:
09/823356
Inventors:
Y. Tang - San Jose CA, US
Olga Bandman - Mountain View CA, US
Preeti Lal - Santa Clara CA, US
Jennifer Hillman - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Neil Corley - Mountain View CA, US
Karl Guegler - Menlo Park CA, US
Matthew Kaser - Castro Valley CA, US
Mariah Baughn - San leandro CA, US
Purvi Shah - Sunnyvale CA, US
Assignee:
Incyte Pharmaceuticals, Inc.
International Classification:
C12Q001/68
C07H021/04
C12P021/02
C07K014/705
C07K016/18
US Classification:
530/350000, 435/006000, 435/069100, 435/325000, 536/023500, 530/388220
Abstract:
The invention provides a human membrane spanning proteins (MSPs) and polynucleotides which identify and encode MSPs. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of MSPs.

Isbn (Books And Publications)

Making And Using Antibodies: A Practical Handbook

Author:
Matthew R. Kaser
ISBN #:
0849335280

Possible Relatives

David A Kaser  Deborah K Kaser  Doris A Kaser  Jack N Kaser  James C Kaser  Jennifer L Kaser  John A Kaser  Matthew F Johnson  Matthew A Stanard  Matthew A Stancil 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.